ES8505409A1 - Procedimiento para purificar interferon de humano - Google Patents

Procedimiento para purificar interferon de humano

Info

Publication number
ES8505409A1
ES8505409A1 ES535509A ES535509A ES8505409A1 ES 8505409 A1 ES8505409 A1 ES 8505409A1 ES 535509 A ES535509 A ES 535509A ES 535509 A ES535509 A ES 535509A ES 8505409 A1 ES8505409 A1 ES 8505409A1
Authority
ES
Spain
Prior art keywords
human interferon
procedure
purify human
cells
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535509A
Other languages
English (en)
Other versions
ES535509A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of ES8505409A1 publication Critical patent/ES8505409A1/es
Publication of ES535509A0 publication Critical patent/ES535509A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

METODO DE PURIFICACION DE INTERFERON DE HUMANO.CONSISTE EN PURIFICAR INTERFERON DE HUMANO DEL TIPO BAB MEDIANTE CROMATOGRAFIA A TRAVES DE UNA COLUMNA DE AFINIDAD DE ANTICUERPO DE IGC, FIJADO COVALENTEMENTE A UN SOPORTE, TAL COMO SEPHAROSE ACTIVADO; SEGUIDO DE LA PURIFICACION A TRAVES DE UN INTERCAMBIADOR DE CATIONES ACIDO.
ES535509A 1983-02-22 1984-08-30 Procedimiento para purificar interferon de humano Granted ES535509A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306060 DE3306060A1 (de) 1983-02-22 1983-02-22 Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ES8505409A1 true ES8505409A1 (es) 1985-05-16
ES535509A0 ES535509A0 (es) 1985-05-16

Family

ID=6191474

Family Applications (2)

Application Number Title Priority Date Filing Date
ES529912A Granted ES529912A0 (es) 1983-02-22 1984-02-21 Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano
ES535509A Granted ES535509A0 (es) 1983-02-22 1984-08-30 Procedimiento para purificar interferon de humano

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES529912A Granted ES529912A0 (es) 1983-02-22 1984-02-21 Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano

Country Status (7)

Country Link
EP (1) EP0119476A3 (es)
JP (1) JPS59224687A (es)
DE (1) DE3306060A1 (es)
DK (1) DK85084A (es)
ES (2) ES529912A0 (es)
FI (1) FI840675L (es)
IL (1) IL71017A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
GB8615353D0 (en) * 1986-06-24 1986-07-30 Antibioticos Sa Interferon
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
SE468251B (sv) 1989-06-20 1992-11-30 Bionative Ab Reningsprocess foer interferon
HUT65846A (en) * 1990-07-10 1994-07-28 Boehringer Ingelheim Int Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing it
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
EP2077858A4 (en) 2006-12-06 2011-07-20 Medimmune Llc INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS
EP2076590A4 (en) 2007-05-03 2011-06-01 Medimmune Llc SELF-IMMUNE DISEASE SELF-ANTIBODY MARKERS
PT2219452E (pt) 2007-11-05 2016-01-26 Medimmune Llc Métodos de tratamento de esclerodermia
SG188147A1 (en) 2008-02-08 2013-03-28 Medimmune Llc Disease markers and uses thereof
US20120251546A1 (en) 2009-09-03 2012-10-04 Medimmune Llc Type 1 inteferon diagnostic
EP3924383A1 (en) 2019-02-15 2021-12-22 Astrazeneca AB Type i interferon-mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
DE3177276D1 (de) * 1980-04-11 1992-04-23 Celltech Ltd Monoklonale antikoerper.
AU561649B2 (en) * 1981-02-27 1987-05-14 F. Hoffmann-La Roche Ag Antibodies to proteins
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
GB8303165D0 (en) * 1983-02-04 1983-03-09 Secher D S Monoclonal antibody

Also Published As

Publication number Publication date
FI840675A7 (fi) 1984-08-23
IL71017A (en) 1987-12-31
IL71017A0 (en) 1984-05-31
FI840675L (fi) 1984-08-23
ES8503371A1 (es) 1985-02-16
ES535509A0 (es) 1985-05-16
DK85084D0 (da) 1984-02-21
DE3306060A1 (de) 1984-08-23
JPS59224687A (ja) 1984-12-17
EP0119476A2 (de) 1984-09-26
ES529912A0 (es) 1985-02-16
EP0119476A3 (de) 1987-04-08
DK85084A (da) 1984-08-23
FI840675A0 (fi) 1984-02-20

Similar Documents

Publication Publication Date Title
PH16642A (en) Complement-fixing monoclonal antibody to human t cells,and methods of preparing same
ES8505409A1 (es) Procedimiento para purificar interferon de humano
NO159888C (no) Monoklonalt antistoff.
AU577745B2 (en) Somatic human hybridoma fusion partner for the production of human monoclonal antibodies
EP0176355A3 (en) Antigen-independent immunoassay system
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
ATE14233T1 (de) Monoklonaler antikoerper gegen menschliche tzellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
PH16819A (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells,antibody and methods
JPS6413990A (en) Hybridoma
NO159887C (no) Monoklonalt antistoff.
ES8200559A1 (es) Un anticuerpo monoclonal
DE3581400D1 (de) Maus/mensch-hybridoma mit erzeugung von antiviralen menschlichen antikoerpern, deren herstellung und antivirale menschliche monoklonale antikoerper.
GB2083836A (en) Monoclonal antibody
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
JPS6447391A (en) Monoclonal antibody and use thereof
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
EP0225583A3 (en) Monoclonal anti-human granulocyte colony stimulating factor antibody
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI820200A7 (fi) Menetelmä vasta-ainetta tuottavien hybridisolujen ja vasta- aineiden valmistamiseksi, hybridisoluja ja vavasta-aineita.
NO874799L (no) Fremgangsmaate for fremstilling av monoklonale antistofferved dyrking av hybridom-cellelinjen lym-2.
HRP940809B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody and methods

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990301